{"id":2698,"date":"2018-12-06T10:15:00","date_gmt":"2018-12-06T10:15:00","guid":{"rendered":"http:\/\/www.irlab.se\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/"},"modified":"2018-12-06T10:15:00","modified_gmt":"2018-12-06T10:15:00","slug":"natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2","status":"publish","type":"post","link":"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/","title":{"rendered":"Natures npj Parkinson\u2019s Disease publicerar klinisk studie med IRLAB:s l\u00e4kemedelskandidat IRL790"},"content":{"rendered":"<p><span>IRL790 &auml;r en av IRLAB:s ledande l&auml;kemedelskandidater och utvecklas f&ouml;r behandling av dyskinesier och psykos vid Parkinsons sjukdom. Den kliniska Fas Ib-studien visar att IRL790 &auml;r v&auml;l tolererad och har en mycket god s&auml;kerhetsprofil. Vidare visades den positiva effekten att dyskinesier minskade i gruppen behandlad med IRL790, men inte i placebogruppen. L&auml;kemedelskandidaten genomg&aring;r nu en klinisk Fas IIa-studie i en st&ouml;rre grupp patienter f&ouml;r vidare studier av den effekt som observerades i Fas Ib-studien.<\/span><\/p>\n<p><span>&rdquo;Att v&aring;r studie nu blir publicerad i tidskriften <em>npj Parkinson&rsquo;s Disease<\/em> validerar v&aring;r forskning och &auml;r sj&auml;lvklart en stor merit f&ouml;r IRLAB, v&aring;ra samarbetspartners och studiens pr&ouml;vningsledare&rdquo;, sade Joakim Tedroff, medicinsk chef (CMO) p&aring; IRLAB.<\/span><\/p>\n<p><em><span>npj Parkinson&rsquo;s Disease <\/span><\/em><span>publiceras av <em>Nature<\/em> och &auml;r en internationell tidskrift som lyfter fram de viktigaste vetenskapliga framstegen inom forskning om Parkinsons sjukdom.<\/span><\/p>\n<p><span>Publikationen: Svenningsson, P. <em>et al<\/em>. <\/span><span>Safety and tolerability of IRL790 in Parkinson&rsquo;s disease with levodopa-induced dyskinesia&mdash;a phase 1b trial. <em>npj Parkinson&rsquo;s Disease<\/em>. DOI-nummer 10.1038\/s41531-018-0071-3.<\/span><\/p>\n<p>L&auml;nk till npj Parkinson&rsquo;s Diesease: <a href=\"https:\/\/www.nature.com\/npjparkd\/\" target=\"_blank\">www.nature.com\/npjparkd\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IRLAB meddelade idag att en publikation baserad p\u00e5 den kliniska Fas Ib-studien med IRL790 i patienter med Parkinsons sjukdom och dyskinesier idag publicerats i den ansedda vetenskapliga tidskriften npj Parkinson\u2019s Disease utgiven av Nature.<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[23],"tags":[],"class_list":["post-2698","post","type-post","status-publish","format-standard","hentry","category-pressmeddelande-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Natures npj Parkinson\u2019s Disease publicerar klinisk studie med IRLAB:s l\u00e4kemedelskandidat IRL790 - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Natures npj Parkinson\u2019s Disease publicerar klinisk studie med IRLAB:s l\u00e4kemedelskandidat IRL790 - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB meddelade idag att en publikation baserad p\u00e5 den kliniska Fas Ib-studien med IRL790 i patienter med Parkinsons sjukdom och dyskinesier idag publicerats i den ansedda vetenskapliga tidskriften npj Parkinson\u2019s Disease utgiven av Nature.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-06T10:15:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Natures npj Parkinson\u2019s Disease publicerar klinisk studie med IRLAB:s l\u00e4kemedelskandidat IRL790\",\"datePublished\":\"2018-12-06T10:15:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/\"},\"wordCount\":232,\"commentCount\":0,\"articleSection\":[\"Pressmeddelande\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/\",\"url\":\"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/\",\"name\":\"Natures npj Parkinson\u2019s Disease publicerar klinisk studie med IRLAB:s l\u00e4kemedelskandidat IRL790 - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2018-12-06T10:15:00+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Natures npj Parkinson\u2019s Disease publicerar klinisk studie med IRLAB:s l\u00e4kemedelskandidat IRL790\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Natures npj Parkinson\u2019s Disease publicerar klinisk studie med IRLAB:s l\u00e4kemedelskandidat IRL790 - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/","og_locale":"sv_SE","og_type":"article","og_title":"Natures npj Parkinson\u2019s Disease publicerar klinisk studie med IRLAB:s l\u00e4kemedelskandidat IRL790 - IRLAB","og_description":"IRLAB meddelade idag att en publikation baserad p\u00e5 den kliniska Fas Ib-studien med IRL790 i patienter med Parkinsons sjukdom och dyskinesier idag publicerats i den ansedda vetenskapliga tidskriften npj Parkinson\u2019s Disease utgiven av Nature.","og_url":"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/","og_site_name":"IRLAB","article_published_time":"2018-12-06T10:15:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/#article","isPartOf":{"@id":"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/"},"author":{"name":"","@id":""},"headline":"Natures npj Parkinson\u2019s Disease publicerar klinisk studie med IRLAB:s l\u00e4kemedelskandidat IRL790","datePublished":"2018-12-06T10:15:00+00:00","mainEntityOfPage":{"@id":"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/"},"wordCount":232,"commentCount":0,"articleSection":["Pressmeddelande"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/","url":"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/","name":"Natures npj Parkinson\u2019s Disease publicerar klinisk studie med IRLAB:s l\u00e4kemedelskandidat IRL790 - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2018-12-06T10:15:00+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/natures-npj-parkinsons-disease-publicerar-klinisk-studie-med-irlabs-lakemedelskandidat-irl790-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"Natures npj Parkinson\u2019s Disease publicerar klinisk studie med IRLAB:s l\u00e4kemedelskandidat IRL790"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/2698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=2698"}],"version-history":[{"count":0,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/2698\/revisions"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=2698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/categories?post=2698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/tags?post=2698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}